Smoking Cessation After CVA/TIA
Introduction to Smoking Cessation
- The European Society of Cardiology recommends intensive behavioral counseling combined with pharmacotherapy for smoking cessation in patients with recent CVA and TIA, starting immediately and extending at least one month beyond hospital discharge to maximize survival and prevent recurrent stroke 1, 2
Importance of Smoking Cessation
- Smoking cessation reduces stroke recurrence risk by 36% and is the single most important modifiable intervention for secondary prevention, according to the European Heart Journal 1, 3
- The health benefits of quitting smoking far outweigh any theoretical medication risks, with smoking cessation associated with a 25-50% reduction in mortality after cardiovascular events, as stated by the American Heart Association 2
Recommended Treatment Algorithm
- The European Society of Cardiology recommends using the "Five A's" approach for intensive behavioral counseling: ASK about smoking status, ADVISE on the importance of quitting, ASSESS readiness to quit, ASSIST with setting a quit date and providing pharmacotherapy, and ARRANGE follow-up support 5, 6
- Combination nicotine replacement therapy (NRT) achieves a 31.5% cessation rate and is explicitly safe in cardiovascular disease patients, including those with established coronary disease and stroke, according to the European Heart Journal 2
- Varenicline achieves a 28% cessation rate and increases cessation 2-3 fold compared to unassisted attempts, with a dosing schedule of 0.5 mg once daily for days 1-3, then 0.5 mg twice daily for days 4-7, then 1 mg twice daily for 12 weeks, as recommended by the European Medicines Agency 5, 6, 2
Essential Follow-Up Structure
- The American College of Cardiology recommends scheduling follow-up within 2 weeks of discharge, continuing monthly contact for at least 4 months, and reassessing at one year to significantly improve outcomes 5, 6